Details van artikel 140 van 177 gevonden artikelen
Reduction in the risk of developing type 2 diabetes (T2D) with liraglutide 3.0mg in individuals with prediabetes and obesity or overweight from the SCALE Obesity and prediabetes randomised, double-blind, placebo-controlled trial
Titel:
Reduction in the risk of developing type 2 diabetes (T2D) with liraglutide 3.0mg in individuals with prediabetes and obesity or overweight from the SCALE Obesity and prediabetes randomised, double-blind, placebo-controlled trial
Auteur:
O’Moore-Sullivan, Trisha Roux, Carel W. Le Astrup, Arne Fujioka, Ken Greenway, Frank Lau, David C.W. van Gaal, Luc Ortiz, Rafael Violante Wilding, John P.H. Skjøth, Trine V. Manning, Linda Shapiro Pi-Sunyer, Xavier
Verschenen in:
Obesity research & clinical practice
Paginering:
Jaargang 13 (2019) nr. 1 pagina's 99
Jaar:
2019
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 140 van 177 gevonden artikelen